Back to News
Market Impact: 0.15
Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?
Source: zacks.com
Corporate EarningsAnalyst Estimates
The article says Johnson & Johnson lacks the two key ingredients for a likely earnings beat in its upcoming report. It provides no specific estimates, figures, or expected share-price impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
JNJ-0.30
More News
- RBC Capital raises Johnson & Johnson stock price target on pharma strength
- A 32% beat, a +6% jump: the IT solutions name our models picked in July
- Nvidia Is on the Verge of a $6 Trillion Market Value
- CNN, CBS News now under one roof as Paramount-Warner Bros merger closes
- GIC Private Ltd, Medline 10% owner, sells over $721m in shares
- U.S. stock futures steady after tech rally lifts S&P 500, Nasdaq to records